FI
NVO

Financial Insights’s Novo Nordisk NVO Stock Holding History

Financial Insights’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,072
Closed -$247K – 134
2024
Q3 		$247K Sell
2,072
-140
-6% -$18.7K 0.08% 130
2024
Q2 		$316K Hold
2,212
– – 0.09% 129
2024
Q1 		$284K Hold
2,212
– – 0.08% 138
2023
Q4 		$229K Hold
2,212
– – 0.07% 148
2023
Q3 		$214K Buy
+2,212
New +$195K 0.08% 141
2021
Q3 		– Sell
-1,750
Closed -$733K – 176
2021
Q2 		$733K Buy
+1,750
New +$67.8K 0.06% 129

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Financial Insights's NVO Position: Q4 2024 in Review

Financial Insights sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 2,072 shares — an estimated $247K sold.

Financial Insights first reported a position in NVO in Q2 2021 and held it in 6 quarters. The position peaked at $733K in Q2 2021. 1,663 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Financial Insights reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Financial Insights sold 2,072 Novo Nordisk shares in Q4 2024, an estimated $247K.
  • Financial Insights first reported a position in Novo Nordisk in Q2 2021 and held it in 6 quarters.
  • Financial Insights's Novo Nordisk position peaked at $733K in Q2 2021.
  • 1,663 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Financial Insights's 13F filing for Q4 2024, filed 5 Mar 2025.